Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
3D Medicines (1244 HK)
Watchlist
14
Analysis
Health Care
•
China
3D Medicines Inc. operates as a commercial-stage biopharmaceutical company. The Company focuses on the development of differentiated immuno-oncology drugs. 3D Medicines conducts businesses in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
01 Nov 2023 14:13
Hong Kong Connect Flows (October): Four Months of Inflows
We analyzed the Hong Kong Connect Scheme for October and highlight flows for Meituan, Wuxi Biologics, SMIC, Great Wall Motor, HKEX.
Ke Yan, CFA, FRM
Follow
289 Views
Share
bearish
•
Quantitative Analysis
•
22 Oct 2023 10:10
Hong Kong Connect Flows (Oct 20th): Meituan
We have analyzed southbound Hong Kong connect flows in the past week and have highlighted flows for Meituan ( 3690 HK ).
Ke Yan, CFA, FRM
Follow
394 Views
Share
bearish
•
Quantitative Analysis
•
15 Oct 2023 10:10
Hong Kong Connect Flows (Oct 13th): Meituan, Tencent
We analyzed the Hong Kong Connect Scheme for last week and highlight weekly flows for Meituan (3690HK) and Tencent (700HK).
Ke Yan, CFA, FRM
Follow
434 Views
Share
bearish
•
3D Medicines
•
22 Jun 2023 08:55
3D Medicines (1244.HK) - The Bubble Will Eventually Burst
3DMed's current stock price is clearly unreasonable. Its financial situation and the prospects of core product indicate that its survival issues...
Xinyao (Criss) Wang
Follow
404 Views
Share
bullish
•
Swire Pacific (B)
•
25 Feb 2023 16:00
HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect
There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...
Brian Freitas
Follow
622 Views
Share
Previous
1
2
3
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x